InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma

Saved in:

Bibliographic Details
Main Authors:	J.S. Weber, J.J. Luke, M.S. Carlino, M.A. Khattak, R. Meehan, M. Brown, J. Zhang, C. Krepler, J.P. Duic, G.V. Long
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001460
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet